Serine hydroxymethyltransferase

From Proteopedia
Revision as of 04:22, 26 November 2013 by Coleman Calva (talk | contribs)
Jump to navigation Jump to search

IntroductionIntroduction

Structure of Serine hydroxymethyltransferase isolated from Bacillus stearothermophilus

Drag the structure with the mouse to rotate

FunctionFunction

Serine hydroxymethyltransferase (SHMT) is part of the pyridoxal phosphate (PLP)-dependent enzymes. The enzyme is broadly classified as a transferase enzyme. Transferase enzymes primarily work by catalyzing the transfer of a specific functional group from one molecule to another. For example, a methyl group may need to be transferred from one molecule to another in vivo. The transferase enzymes will catalyze the transfer of this methyl group.

Specifically, the enzyme belongs to the alpha-class. This enzyme is utilized mainly for two functions. First, the enzyme catalyzes the reversible conversion of L-serine to L-glycine. Second, the enzyme catalyzes the reversible conversion of tetrahydrofolate to 5,10-methylene tetrahydrofolate. The mechanism for the interconversion of both molecules is shown below.

File:SHMT Function.jpg
Enzymatic Function of SHMT

Diversity/ImportanceDiversity/Importance

There appear to be multiple isoforms of the enzyme in bacteria. Serine hydroxymethyltransferase isoforms have namely been identified from Escherichia coli and Bacillus stearothermophilus. In mammals, there are two separate isoforms of SHMT in the cytoplasm and the mitochondria. In plants, there is an additional SHMT isoform found within the chloroplast. The diverse presence of serine hydroxymethyltransferase is in part because of the importance of 5,10-methylene tetrahydrofolate. This intermediate is important for the synthesis of the essential biomolecules purine, thymidine, choline, and methionine. Serine hydroxymethyltransferase plays a very important role in the Smith-Magneis syndrome (SMS). SHMT is also being studied in the field of anti-cancer and anti-microbials drugs.

FoldingFolding

The enzyme monomer fold is comprised of the c-terminal domain and the N-Terminal Domain. The C-terminal domain folds into an αβ sandwich. The N-terminal domain is comprised of two further domains. The first N-terminal sub-domain is a smaller domain composed of only 3 α-helices and 1 β-strand. The second N-terminal subdomain is the PLP binding domain. This sub-domain folds into an αβα structure that has a seven-stranded mixed β sheet surrounded by α-helices on both sides, hence αβα.

StructureStructure

Mechanism of ActionMechanism of Action

The most common accepted mechanism of action is through a process called retro-aldol cleavage.

ImplicationsImplications

This enzyme has important implications in disease and medicine. Smith-Magneis syndrome (SMS) is a genetic disorder in which there is a defect in the short arm of chromosome 17. This disease causes mental retardation, behavioral problems, and gives the affected person an obvious set of facial features. The defect results in approximately a 50% loss of cytosolic-SHMT present in individuals. If there is less SHMT than needed, the products any SHMT catalyzed-reaction would be deficient.

One potential application for SHMT is in cancer-therapeutics. The enzyme is an important factor in rapidly dividing cells. This knowledge could turn into the development of a potential anti-cancer drug that inhibits the function of serine hydroxymethyltransferase

ReferencesReferences

</StructureSection>

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Coleman Calva, Michal Harel, Alexander Berchansky, Jaime Prilusky, Karsten Theis